Target Selectivity of Cabozantinib (XL184)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| VEGFR2 | 0.03 nM | -- | PMC12718917 |
| RET | 0.03 nM | -- | PMC12718917 |
| c-KIT | 0.03 nM | -- | PMC12718917 |
| FLT3 | 0.03 nM | -- | PMC12718917 |
| TIE2 | 0.03 nM | -- | PMC12718917 |
| CSF-1R | 0.03 nM | -- | PMC12718917 |
| PDGFRα | 0.03 nM | -- | PMC12718917 |
| Src | 0.03 nM | -- | PMC12718917 |
| ABL | 0.03 nM | -- | PMC12718917 |
| VEGFR2 | 0.035 nM | tyrosine kinase activity assay | PMC9324961 |
| KDR | 0.035 nM | In vitro assay | PMC5873445 |
| VEGFR2 | 0.035 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| AXL | 0.7 nM | -- | PMC12718917 |
| MET | 1.3 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| c-MET | 1.3 nM | -- | PMC12718917 |
| c-Met | 1.8 nM | tyrosine kinase activity assay | PMC9324961 |
| RET | 4 nM | tyrosine kinase activity assay | PMC9324961 |
| c-KIT | 4.6 nM | In vitro assay | PMC5873445 |
| KIT | 4.6 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| RET | 5.2 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| AXL | 7 nM | In vitro assay | PMC5873445 |
| AXL | 7 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| FLT-3 | 11.3 nM | In vitro assay | PMC5873445 |
| FLT3 | 11.3 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| TIE-2 | 14.3 nM | In vitro assay | PMC5873445 |
| TIE-2 | 14.3 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| c-Met | 0.03 µM | BPS KDR Assay Kit | PMC10026756 |
| VEGFR-2 | 0.059 µM | BPS KDR Assay Kit | PMC10026756 |
| RON | 124 nM | half maximal inhibitory concentration [IC50] | PMC7395054 |
| EGFR | 600 nM | -- | PMC12718917 |
| RAF | 600 nM | -- | PMC12718917 |
| TKRB | 600 nM | -- | PMC12718917 |
Check the
Cabozantinib (XL184)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Cabozantinib (XL184) Mechanism of Action: VEGFR2 Inhibition in Endothelial Cells Research
- Cabozantinib (XL184) Clinical Trials
- Cabozantinib (XL184) Working Concentration | Cell Culture | Treatment
- Cabozantinib (XL184) Solubility in DMSO
- Cabozantinib (XL184) Stock Solution
- Cabozantinib (XL184) Storage
- Cabozantinib (XL184) Stability
- Cabozantinib (XL184) Combination Database
- Cabozantinib (XL184) Molecular Weight
- Cabozantinib (XL184) SMILES
- Cabozantinib (XL184) CAS Number
- Cabozantinib (XL184) Chemical Structure (2D and 3D)
- Cabozantinib (XL184) IC50 for Cell-based and Cell-free Assays
- Cabozantinib (XL184) Sigma (SML3914)? Try a better option.
- Cabozantinib (XL184) MedChemExpress (HY-13016)? Try a better option.
- Cabozantinib (XL184) APExBIO (A2977)? Try a better option.
- Cabozantinib (XL184) Cayman (18464)? Try a better option.
- Cabozantinib (XL184) Tocris (5422)? Try a better option.
- Cabozantinib (XL184) SDS|MSDS